Start activity
Videos Take CE/CME Test
COVID-19, Vaccines, Viral Infections, Respiratory Infections CE/CME accredited

A visually engaging discussion designed to emulate a ‘live’ panel experience and provide clinicians with practical expert insights to address their clinical challenges. Useful tips below will show how to navigate the activity. Close

Reducing transmission of COVID-19: Spotlight on vaccines

  • Select in the video player controls bar to choose subtitle language. Subtitles available in English, French, Turkish.
  • Downloads including slides are available for this activity in the Toolkit
Learning Objectives

After watching this activity, participants should be better able to:

  • Summarize the current COVID-19 vaccination landscape
  • Identify factors contributing to differential uptake of COVID-19 vaccines in population subsets
  • Evaluate strategies to improve COVID-19 vaccine uptake
  • Discuss the future of COVID-19 vaccination, including how vaccine inequity may be addressed

In this activity, three experts discuss the current landscape of COVID-19 vaccination, possible barriers to vaccine uptake and strategies involving healthcare workers that may help to improve acceptance of the COVID-19 vaccine, with a focus on Africa and the Middle East. The discussion is guided by pre-canvassed questions provided by respiratory and infectious diseases specialists and primary care providers working in Africa and the Middle East.

This activity is jointly provided by USF Health and touchIME. read more

Target Audience

This activity has been designed to meet the educational needs of infectious disease specialists, respiratory disease specialists and primary care providers involved in the management of people with COVID-19 infection or the administration of the COVID-19 vaccines.


USF Health adheres to the Standards for Integrity and Independence in Accredited Continuing Education. All individuals in a position to influence content have disclosed to USF Health any financial relationship with an ineligible organization. USF Health has reviewed and mitigated all relevant financial relationships related to the content of the activity.  The relevant relationships are listed below. All individuals not listed have no relevant financial relationships.


Dr Angus Thomson has no relevant financial disclosures in relation to this educational activity. 

Dr Amaya Gillespie has no relevant financial disclosures in relation to this educational activity.

Dr Henry Kyobe Bosa has no relevant financial disclosures in relation to this educational activity. 

Content reviewer

Sally F. Alrabaa, MD has no relevant financial disclosures in relation to this educational activity.

Touch Medical Directors

Hannah Fisher has no financial interests/relationships or affiliations in relation to this activity.

USF Health Office of Continuing Professional Development and touchIME staff have no financial interests/relationships or affiliations in relation to this activity.

Requirements for Successful Completion

In order to receive credit for this activity, participants must review the content and complete the post-test and evaluation form. Statements of credit are awarded upon successful completion of the post-test and evaluation form.

If you have questions regarding credit please contact



This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through a joint providership of USF Health and touchIME. USF Health is accredited by the ACCME to provide continuing medical education for physicians.

USF Health designates this enduring material for a maximum of 1.25 AMA PRA Category 1 CreditTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The European Union of Medical Specialists (UEMS) – European Accreditation Council for Continuing Medical Education (EACCME) has an agreement of mutual recognition of continuing medical education (CME) credit with the American Medical Association (AMA). European physicians interested in converting AMA PRA Category 1 CreditTM into European CME credit (ECMEC) should contact the UEMS (

Advanced Practice Providers

Physician Assistants may claim a maximum of 1.25 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 CreditTM from organizations accredited by ACCME or a recognized state medical society.

The AANPCP accepts certificates of participation for educational activities approved for AMA PRA Category 1 CreditTM by ACCME-accredited providers. APRNs who participate will receive a certificate of completion commensurate with the extent of their participation.

Date of original release: 26 April 2023. Date credits expire: 26 April 2024.

If you have any questions regarding credit please contact

This activity is CE/CME accredited

To obtain the CE/CME credit(s) from this activity, please complete this post-activity test.

Claim Credit

Topics covered in this activity

COVID-19 / Vaccines / Viral Infections / Respiratory Infections
  • 1000+ topical and insightful peer-reviewed journal articles
  • 100+ hours of bite-sized congress highlights
  • 9 major therapy areas packed with the latest scientific advances
  • 150+ specialties offering learn-on-the-go medical education
  • + Concise email updates and newsletters so you never miss out
Register For Free Now
Claim Credit
Reducing transmission of COVID-19: Spotlight on vaccines
1.25 CE/CME credit

Question 1/5
As of March 2023, which of the following statements regarding COVID-19 vaccination is true?

Globally, there remain major disparities in COVID-19 vaccine access and uptake. Africa and the Middle East are among the regions with the lowest number of people vaccinated. Within these regions, there are also large disparities. For example, as of January 2023, 106% of people in Qatar have received at least one dose of a COVID-19 vaccine, compared with only 26% of people in Iraq.


Our World In Data. Available at: (accessed 15 March 2023).

Question 2/5
Based on the WHO SAGE roadmap for prioritizing the use of COVID-19 vaccines, which of the following groups would you prioritize for vaccination?

SAGE, Strategic Advisory Group of Experts; WHO, World Health Organization.

To assist countries in developing recommendations for optimized use of vaccines against COVID-19, the WHO has developed a roadmap that identifies three priority-use groups (high, medium and low) for vaccination based on epidemiological scenarios, public health goals and vaccine coverage scenarios. Within the roadmap, the high priority group includes older adults, younger adults with significant comorbidities, people with immunocompromising conditions, pregnant persons and frontline health workers.


WHO, World Health Organization.


WHO. SAGE updates COVID-19 vaccination guidance. Available at: (accessed 31 March 2023).

Question 3/5
You recommend the COVID-19 vaccine to a 60-year-old woman in your clinic. She has a general lack of trust in vaccines; however, after a lengthy discussion on the benefits of the COVID-19 vaccine, she agrees. She is a retired librarian who lives on her own; she has limited mobility and is unable to drive. Based on this information, which factors would you identify as her biggest barriers to vaccine uptake?

Convenience of access to vaccination is related to increased vaccine uptake.1 In this scenario, the woman may find it difficult to attend her vaccine appointment due to her mobility issues and lack of personal transport.

Acceptance is the degree to which individuals accept, question or refuse the vaccination.1 Effective strategies to tackle low trust in vaccines include recommendations from health professionals, vaccine champions and advocates, positive social norm messages and community engagement.2


  1. Thomson A, et al. Vaccine. 2016;34:1018–24.
  2. WHO. Weekly Epidemiological Record. No 20. 2022;97:209–24.
Question 4/5
You work at a clinic in a rural town, 2 hours away from a major city. The majority of the community congregate at the local place of worship each Sunday. You are hearing that many people are hesitant to be vaccinated against COVID-19, and despite offering flexible opening hours at your clinic, you are still seeing a low vaccine uptake. How would you best approach increasing vaccine uptake in this population?

Trustworthy figures (e.g. religious leaders) can play a major role in saving lives and reducing illness related to COVID-19 in a community. They are a primary source of support, comfort, guidance, and direct health care and social service, for the communities they serve. Religious leaders of faith-based organizations and communities of faith can share health information to protect their own members and wider communities, which may be more likely to be accepted than from other sources.


WHO. Practical considerations and recommendations for religious leaders and faith-based communities in the context of COVID-19. Available at: (accessed 15 March 2023).

Question 5/5
Your region has high vaccination rates and is now considering how to integrate COVID-19 vaccination into a routine immunization programme. What would you suggest to optimize vaccination rates?

The WHO and UNICEF published a joint report detailing the considerations for integrating COVID-19 vaccination into immunization programmes and primary healthcare for 2022 and beyond. Providing COVID-19 vaccination alongside other health interventions as a package of services, especially in the face of competing health priorities, will increase efficiency and programme performance.


UNICEF, United Nations Children’s Fund; WHO, World Health Organization


WHO and UNICEF. Considerations for integrating COVID-19 vaccination into immunization programmes and primary health care for 2022 and beyond Available at: (accessed 15 March 2023).

Back to Activity
Copied to clipboard!
accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Sponsored Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72